We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Complianţa și tolerabilitatea pacientelor cu cancer de sân la administrarea inhibitorilor de aromatază.
- Authors
AtodireseiPavalache, Georgiana; Munteanu, Denis
- Abstract
Aromatase inhibitors (AIs) represent a class of oncological drugs used in the treatment of patients with hormonepositive breast cancer. As a result of the action they exert on the cancerous tissue, unlike their precursors (for example, tamoxifen), this class is considered to be the first-choice treatment in breast cancer for postmenopausal patients. Thus, due to the increased effectiveness, this study was intended to analyze the compliance and tolerability of patients from Iași city to this treatment, comparing the data thus obtained with a study conducted in 2021 in Wisconsin, USA. It should be noted that the patients who were included in the present study generally did not receive other oncological treatments, which determined the objective analysis of adverse reactions to AIs.
- Publication
Farmacist.ro, 2024, Vol 216, Issue 1, p22
- ISSN
1584-6539
- Publication type
Article